| 1 | 20 mg sildenafil citrate by mouth (D08514) | [1] Sildenafil Sildenafil | [1] Sildenafil
Sildenafil
(D08514) 💬
| [1] PDE5A PDE5A 💬
| [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬
|
| 2 | 5% sildenafil cream (D08514) | [1] Sildenafil Sildenafil | [1] Sildenafil
Sildenafil
(D08514) 💬
| [1] PDE5A PDE5A 💬
| [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 50 50 💬
|
| 3 | Access program - sildenafil citrate, Viagra, Revatio (D08514) | [1] Sildenafil Sildenafil | [1] Sildenafil
Sildenafil
(D08514) 💬
| [1] PDE5A PDE5A 💬
| [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬
|
| 4 | Bosentan and Sildenafil (D08514) | [2] Bosentan Bosentan, Sildenafil | [3] Bosentan
Bosentan
,
Bosentan
,
Sildenafil
(D08514) 💬
| [3] EDNRA EDNRA, EDNRB, PDE5A 💬
| [11] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬
|
| 5 | Duo-Therapy with Sildenafil + Bosentan (D08514) | [2] Bosentan Bosentan, Sildenafil | [3] Bosentan
Bosentan
,
Bosentan
,
Sildenafil
(D08514) 💬
| [3] EDNRA EDNRA, EDNRB, PDE5A 💬
| [11] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬
|
| 6 | ERA and PDE-5I (Sildenafil, Tadalafil, Bosentan, Macitentan) (D08514) | [4] Bosentan Bosentan, Macitentan, Sildenafil, Tadalafil | [5] Bosentan
Bosentan
,
Tadalafil
,
Bosentan
,
Sildenafil
(D08514),
Macitentan
💬
| [3] EDNRA EDNRA, EDNRB, PDE5A 💬
| [11] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬
|
| 7 | G04BE03- Sildenafil - sildenafil (citrato) (D08514) | [1] Sildenafil Sildenafil | [1] Sildenafil
Sildenafil
(D08514) 💬
| [1] PDE5A PDE5A 💬
| [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬
|
| 8 | Mono-Therapy with Sildenafil (D08514) | [1] Sildenafil Sildenafil | [1] Sildenafil
Sildenafil
(D08514) 💬
| [1] PDE5A PDE5A 💬
| [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬
|
| 9 | Oral sildenafil (D08514) | [1] Sildenafil Sildenafil | [1] Sildenafil
Sildenafil
(D08514) 💬
| [1] PDE5A PDE5A 💬
| [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬
|
| 10 | Sildenafil (D08514) | [1] Sildenafil Sildenafil | [1] Sildenafil
Sildenafil
(D08514) 💬
| [1] PDE5A PDE5A 💬
| [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [17] 6 6, 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬
|
| 11 | Sildenafil (50 mg) (D08514) | [1] Sildenafil Sildenafil | [1] Sildenafil
Sildenafil
(D08514) 💬
| [1] PDE5A PDE5A 💬
| [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 85 85 💬
|
| 12 | Sildenafil (Acute-1 hour) (D08514) | [1] Sildenafil Sildenafil | [1] Sildenafil
Sildenafil
(D08514) 💬
| [1] PDE5A PDE5A 💬
| [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 299 299 💬
|
| 13 | Sildenafil (as citrate) (D08514) | [1] Sildenafil Sildenafil | [1] Sildenafil
Sildenafil
(D08514) 💬
| [1] PDE5A PDE5A 💬
| [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬
|
| 14 | Sildenafil (REVATIO) (D08514) | [1] Sildenafil Sildenafil | [1] Sildenafil
Sildenafil
(D08514) 💬
| [1] PDE5A PDE5A 💬
| [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬
|
| 15 | Sildenafil (Revatio) 20 mg TID (D08514) | [1] Sildenafil Sildenafil | [1] Sildenafil
Sildenafil
(D08514) 💬
| [1] PDE5A PDE5A 💬
| [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬
|
| 16 | Sildenafil (Subchronic-4 weeks) (D08514) | [1] Sildenafil Sildenafil | [1] Sildenafil
Sildenafil
(D08514) 💬
| [1] PDE5A PDE5A 💬
| [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 299 299 💬
|
| 17 | Sildenafil 20 mg tablets (D08514) | [1] Sildenafil Sildenafil | [1] Sildenafil
Sildenafil
(D08514) 💬
| [1] PDE5A PDE5A 💬
| [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 278 278 💬
|
| 18 | Sildenafil 20mg (D08514) | [1] Sildenafil Sildenafil | [1] Sildenafil
Sildenafil
(D08514) 💬
| [1] PDE5A PDE5A 💬
| [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [2] 51 51, 86 💬
|
| 19 | Sildenafil 20mg and Bosentan 62.5mg (D08514) | [2] Bosentan Bosentan, Sildenafil | [3] Bosentan
Bosentan
,
Bosentan
,
Sildenafil
(D08514) 💬
| [3] EDNRA EDNRA, EDNRB, PDE5A 💬
| [11] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 51 51, 86 💬
|
| 20 | Sildenafil 40mg oral capsule (D08514) | [1] Sildenafil Sildenafil | [1] Sildenafil
Sildenafil
(D08514) 💬
| [1] PDE5A PDE5A 💬
| [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 299 299 💬
|
| 21 | Sildenafil and Losartan (D08514) | [2] Losartan Losartan, Sildenafil | [2] Losartan
Losartan
,
Sildenafil
(D08514) 💬
| [2] AGTR1 AGTR1, PDE5A 💬
| [18] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Purine metabolism, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 85 85 💬
|
| 22 | Sildenafil by injection (D08514) | [1] Sildenafil Sildenafil | [1] Sildenafil
Sildenafil
(D08514) 💬
| [1] PDE5A PDE5A 💬
| [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 210 210 💬
|
| 23 | SILDENAFIL CITRATE (D08514) | [1] Sildenafil Sildenafil | [1] Sildenafil
Sildenafil
(D08514) 💬
| [1] PDE5A PDE5A 💬
| [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [4] 51 51, 85, 86, 225 💬
|
| 24 | Sildenafil citrate (UK-92,480) (D08514) | [1] Sildenafil Sildenafil | [1] Sildenafil
Sildenafil
(D08514) 💬
| [1] PDE5A PDE5A 💬
| [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬
|
| 25 | Sildenafil Filmtabletten (D08514) | [1] Sildenafil Sildenafil | [1] Sildenafil
Sildenafil
(D08514) 💬
| [1] PDE5A PDE5A 💬
| [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬
|
| 26 | Sildenafil Oral Suspension (D08514) | [1] Sildenafil Sildenafil | [1] Sildenafil
Sildenafil
(D08514) 💬
| [1] PDE5A PDE5A 💬
| [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 294 294 💬
|
| 27 | Sildenafil singly or in association with Bosentan (D08514) | [2] Bosentan Bosentan, Sildenafil | [3] Bosentan
Bosentan
,
Bosentan
,
Sildenafil
(D08514) 💬
| [3] EDNRA EDNRA, EDNRB, PDE5A 💬
| [11] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬
|
| 28 | Sildenafil therapy (D08514) | [1] Sildenafil Sildenafil | [1] Sildenafil
Sildenafil
(D08514) 💬
| [1] PDE5A PDE5A 💬
| [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 51 51 💬
|
| 29 | Sitaxsentan and Sildenafil (D08514) | [2] Sildenafil Sildenafil, Sitaxentan | [2] Sitaxentan
Sitaxentan
,
Sildenafil
(D08514) 💬
| [2] EDNRA EDNRA, PDE5A 💬
| [9] Calcium signaling pathway Calcium signaling pathway, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬
|
| 30 | Sodium tanshinone IIA sulfonate diluted with 5% glucose solution,20mg sildenafil citrate by mouth (D08514) | [2] Dextrose, unspecified form Dextrose, unspecified form, Sildenafil | [1] Sildenafil
Sildenafil
(D08514) 💬
| [1] PDE5A PDE5A 💬
| [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬
|
| 31 | Tadalafil and Sildenafil (D08514) | [2] Sildenafil Sildenafil, Tadalafil | [2] Tadalafil
Tadalafil
,
Sildenafil
(D08514) 💬
| [1] PDE5A PDE5A 💬
| [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 113 113 💬
|